Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




A Miniature Mechanical Pump Helps Weak Hearts

By HospiMedica staff writers
Posted on 05 May 2008
An implantable left ventricular assist system (LVAS) sustains patients awaiting heart transplant, gives them a better quality of life, and improved chances of survival.

The HeartMateII LVAS the HeartMate II is intended for left, right, and biventricular support for bridge-to-heart transplantation and for post-cardiotomy recovery. More...
The device provides continuous blood flow through the circulatory system using only one moving part - a rotary pumping mechanism. At the heart of the system pump is a flattened titanium cylinder about five cm thick and 10 cm in circumference, and weighing 1.2 kg. The pump has two chambers: a blood chamber and a motor chamber. A flexible membrane separates the two, which moves up and down when pushed by the motor. The inside of the pump is made of beaded titanium, which creates a rough, textured surface. The other side is made of textured polyurethane, which helps the body form a lining inside the pump, mimicking the blood vessels. The HeartMate pump contains unidirectional valves that allow the blood flow only from the left ventricle through the pump and out to the body. The HeartMate can pump up to 10 liters per minute.

The system includes the implantable heart pump and a driveline that connects it to the system controller. The system also includes a power base unit (PB), used for charging batteries and for powering the pump while the patient is at rest, and a display module to show pump information. The device has been designed to be quieter and more durable than most other pumps, and is only one-eighth the size of the original HeartMate LVAS. The HeartMate II is manufactured by Thoratec (Pleasanton, CA, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

"For patients whose hearts are unable to effectively pump blood due to severe heart failure, this remarkable device can help them have active lives as they await a heart transplant,” said Dr. Yoshifumi Naka, M.D., director of cardiac transplantation at NewYork-Presbyterian Hospital/Columbia University Medical Center (New York, NY, USA) and associate professor of surgery at Columbia University College of Physicians and Surgeons (New York, NY, USA).


Related Links:
Thoratec
NewYork-Presbyterian Hospital/Columbia University Medical Center

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Electrode Solution and Skin Prep
Signaspray
Silver Member
ECG Management System
NEMS Web
Critical Care Conversion Kit
Adapter+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.